Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1998Leukemia & lymphoma/Leukemia and lymphoma

The Expression of T Cell Related Costimulatory Molecules in Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRD BrownSouthwest Research InstituteBYBenjamin YuenSunesis (United States)JGJohn GibsonClinical Trial Investigators

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brown et al. (1998) studied this question.

synapsesocial.com/papers/6a0ff7a9b6f5ee04016026d5https://doi.org/10.3109/10428199809059231
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct1996 · 156 citations
  2. 2Abnormal monoclonal antibody‐defined helper/suppressor T‐cell subpopulations in multiple myeloma: relationship to treatment and clinical stage1983 · 130 citations
  3. 3CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling1993 · 115 citations
  4. 4Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myeloma1997 · 35 citations
  5. 5B7, a B-cell-restricted antigen that identifies preactivated B cells.1987 · 209 citations